BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 25681439)

  • 1. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
    Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
    J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interaction between Bcl-xL and the voltage-dependent anion channel (VDAC) promotes mitochondrial Ca2+ uptake.
    Huang H; Hu X; Eno CO; Zhao G; Li C; White C
    J Biol Chem; 2013 Jul; 288(27):19870-81. PubMed ID: 23720737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
    Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-xL acts as an inhibitor of IP
    Rosa N; Ivanova H; Wagner LE; Kale J; La Rovere R; Welkenhuyzen K; Louros N; Karamanou S; Shabardina V; Lemmens I; Vandermarliere E; Hamada K; Ando H; Rousseau F; Schymkowitz J; Tavernier J; Mikoshiba K; Economou A; Andrews DW; Parys JB; Yule DI; Bultynck G
    Cell Death Differ; 2022 Apr; 29(4):788-805. PubMed ID: 34750538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIRD-2, a BH4-domain-targeting peptide of Bcl-2, provokes Bax/Bak-independent cell death in B-cell cancers through mitochondrial Ca
    Kerkhofs M; La Rovere R; Welkenhuysen K; Janssens A; Vandenberghe P; Madesh M; Parys JB; Bultynck G
    Cell Calcium; 2021 Mar; 94():102333. PubMed ID: 33450506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein.
    Arbel N; Ben-Hail D; Shoshan-Barmatz V
    J Biol Chem; 2012 Jun; 287(27):23152-61. PubMed ID: 22589539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond.
    Monaco G; Vervliet T; Akl H; Bultynck G
    Cell Mol Life Sci; 2013 Apr; 70(7):1171-83. PubMed ID: 22955373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain.
    Vervliet T; Lemmens I; Vandermarliere E; Decrock E; Ivanova H; Monaco G; Sorrentino V; Nadif Kasri N; Missiaen L; Martens L; De Smedt H; Leybaert L; Parys JB; Tavernier J; Bultynck G
    Sci Rep; 2015 Apr; 5():9641. PubMed ID: 25872771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.
    Monaco G; Decrock E; Akl H; Ponsaerts R; Vervliet T; Luyten T; De Maeyer M; Missiaen L; Distelhorst CW; De Smedt H; Parys JB; Leybaert L; Bultynck G
    Cell Death Differ; 2012 Feb; 19(2):295-309. PubMed ID: 21818117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VDAC1 functions in Ca
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A
    Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death.
    Shimizu S; Konishi A; Kodama T; Tsujimoto Y
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3100-5. PubMed ID: 10737788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IP
    Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
    BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity.
    Arbel N; Shoshan-Barmatz V
    J Biol Chem; 2010 Feb; 285(9):6053-62. PubMed ID: 20037155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
    Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial VDAC, the Na
    Shoshan-Barmatz V; De S
    Adv Exp Med Biol; 2017; 981():323-347. PubMed ID: 29594867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator.
    Shimizu S; Shinohara Y; Tsujimoto Y
    Oncogene; 2000 Sep; 19(38):4309-18. PubMed ID: 10980606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The non-apoptotic action of Bcl-xL: regulating Ca(2+) signaling and bioenergetics at the ER-mitochondrion interface.
    Williams A; Hayashi T; Wolozny D; Yin B; Su TC; Betenbaugh MJ; Su TP
    J Bioenerg Biomembr; 2016 Jun; 48(3):211-25. PubMed ID: 27155879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis.
    Vervliet T; Gerasimenko JV; Ferdek PE; Jakubowska MA; Petersen OH; Gerasimenko OV; Bultynck G
    Cell Death Discov; 2018; 4():58. PubMed ID: 29760956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
    Front Oncol; 2017; 7():154. PubMed ID: 28824871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.